Fortrea rolled out an AI-powered clinical trial services suite built around its FIT platform, aiming to improve trial efficiency and reduce risk in execution. The CRO said the technology supports sponsors and sites with data-driven monitoring and decision-making, while components are also available through Fortrea’s software-as-a-service offering. Fortrea framed the launch as a response to evolving clinical development needs and described FIT as “human-centered,” built using input from sponsors and investigators and designed to integrate responsible and ethical AI usage. The company also cited progress toward modernizing risk-based monitoring tools in prior reporting. For biotech teams, CRO AI tooling has immediate relevance for feasibility, monitoring intensity, and operational timelines, particularly as decentralization and hybrid trial structures increase complexity in data management and site workflows.